ANDA 78502, held by Cypress Pharm. Calcium Acetate.
As of Nov 16, 2026, ANDA 78502 (Eliphos), held by Cypress Pharm, was first approved by FDA on Nov 24, 2008, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 24, 2008 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Eliphos667MG · tablet;oral | Calcium Acetate | Discontinued |
| Jul 12, 2012 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jun 3, 2009 | Supplement 5Labeling | Approved | None posted |
| Mar 20, 2009 | Supplement 3Labeling | Approved | None posted |
| Mar 18, 2009 | Supplement 4Labeling | Approved | None posted |
| Jan 21, 2009 | Supplement 2Labeling | Approved | None posted |
| Nov 24, 2008 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters